Altos Labs

Biotech · Private

Cellular reprogramming technology to reverse aging and restore cellular function

altoslabs.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
4 granted · 36 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1778Alpine Bio——
1779Ravata Solutions, Inc.——
1780Cartography Biosciences——
1781Altos Labs——
1782BIOMORPH TECHNOLOGIES LLC——
1783LIPO-IMMUNO TECH, LLC——
1784Sisu Pharma, Inc.—$1.7M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 4 granted of 40
  • Mechanistic Chromatin Modeling With Iterative Optimization, Nuclear Envelope Interactions, And Editable Epigenetic Compositionapplication
  • ATF6 Modulators And Uses Thereofgranted
  • Optimizing The Transmission Of Semantic Information In Biocommunication Systemsapplication
  • Compounds For Treatment Of Osteoarthritisgranted
  • Semantic Segmentation Of Sparse Multi-dimensional Tensorsgranted
  • Methods For Decreasing Or Inhibiting Human L1 Retrotransposon Rna And Compositions For Use Thereinapplication
  • Perturbation Response And Target Cell State Modelingapplication
  • ATF6 Inhibitors And Uses Thereofgranted
  • Modulators Of Integrated Stress Response Pathwayapplication
  • Inhibitors Of Integrated Stress Response Pathwayapplication
  • ATF6 Modulators And Uses Thereofapplication
  • Inhibitors Of Integrated Stress Response Pathwayapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.